Literature DB >> 3064939

[Seroprevalence of syphilis in urban and semi-rural populations of Gabon].

A Dupont1, D Schrijvers, E Delaporte, M Merlin, R Josse, H Cheringou, L Bedjabaga, E Frost, M Le Bras.   

Abstract

The seroprevalence of syphilis was studied in an urban and a semi-rural community in Gabon by a cluster sampling technique. The crude prevalence rate of treponemal infection in the semi-rural population was estimated to be 13.3 +/- 5.0% and in the urban population 19.4 +/- 4.6%. The age-adjusted prevalence rate was significantly higher in the urban than in the semi-rural population. In both areas, it was significantly higher in men than in women. No significant difference was observed according to age. These high rates indicate the need for a control program for sexually transmitted diseases.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3064939

Source DB:  PubMed          Journal:  Bull Soc Pathol Exot Filiales


  4 in total

1.  Seroprevalence of HIV, hepatitis B, and syphilis in an urban population and isolated villages in Gabon.

Authors:  E Bertherat; R Nabias; M C Georges-Courbot; A Renaut
Journal:  Sex Transm Infect       Date:  1999-08       Impact factor: 3.519

2.  Syphilis serology in patients with primary syphilis and non-treponemal sexually transmitted diseases in southern Africa.

Authors:  A Sischy; F da L'Exposto; Y Dangor; H G Fehler; F Radebe; D D Walkden; S D Miller; R C Ballard
Journal:  Genitourin Med       Date:  1991-04

3.  Transmission of syphilis between sexual partners in Gabon.

Authors:  D Schrijvers; R Josse; A Trebucq; A Dupont; H Cheringou; B Larouzé
Journal:  Genitourin Med       Date:  1989-04

4.  Decline in the seroprevalence of syphilis markers among first-time blood donors in Libreville (Gabon) between 2004 and 2016.

Authors:  Cyrille Bisseye; Jean-Marie Eko Mba; Jophrette Mirelle Ntsame Ndong; Heidi E Kosiorek; Richard J Butterfield; Landry Erik Mombo; Bertrand M'batchi; Mitesh J Borad; Bolni Marius Nagalo; Jean-Pierre Allain
Journal:  BMC Public Health       Date:  2019-02-08       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.